Governor Tom Wolf announced that 23 awardees will receive $10 million in grant funding through the COVID-19 Vaccines, Treatments and Therapies (CV-VTT) program to support the rapid advancement of vaccines, treatments and therapies by qualified biotechnology entities in response to the COVID-19 pandemic.
Evrys Bio was awarded over $300,000 to develop treatments for virus caused respiratory infections. To date, Evrys Bio has seen excellent activity of certain proprietary pre-clinical leads against both corona viruses and influenza viruses.
